Urolithin A mitigates doxorubicin-induced myocardial injury via suppression of ROS-driven apoptotic signaling.

PubMed 2026

View at publisher
Authors: Wei Song, Mei Chen, Lin Pang, Jincheng Wu, Xianxing Zhao, Tianyao Ma, Pu Zhang, Hong Yang, Xianjun Wang
DOI: 10.14670/hh-25-054
Cited by: 0
References: 1

Abstract

BACKGROUND: were investigated. METHODS: protective mechanism. RESULTS: . CONCLUSION: by inhibiting ROS-driven apoptosis, which yields significant insights for combating DOX-mediated myocardial injury.

Fields of Study & Subjects

Chemotherapy-induced cardiotoxicity and mitigation Cardiac Ischemia and Reperfusion Bioactive Compounds and Antitumor Agents

Publication details

Journal / source
PubMed
Volume
41
Issue
9
Pages
1585–1596
Publication date
1 September 2026
Language
EN